These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8338779)

  • 1. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing.
    Ljungman P; de Witte T; Verdonck L; Gahrton G; Freycon F; Gravett P; McCann S; Morgenstern HG; Nikoskelainen J; Powles R
    Br J Haematol; 1993 May; 84(1):61-6. PubMed ID: 8338779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for acute myeloid leukemia: the EBMT experience. A prospective analysis from HLA-typing. The EMBT Leukemia Working Party.
    Gratwohl A; Ljungman P; de Witte T; Verdonck L; Freyçon F; Gravett P; McCann S; Morgenstern HG; Nikoskelainen J; Powles R
    Leukemia; 1992; 6 Suppl 2():110-3. PubMed ID: 1578908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
    Ringdén O; Labopin M; Gluckman E; Hows JM; Bradley BA; Kolb HJ; Fouillard L; Jacobsen N; Vernant JP; Witz F; Harousseau JL; Gorin NC
    Bone Marrow Transplant; 1997 May; 19(10):963-8. PubMed ID: 9169639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Cahn JY; Labopin M; Sierra J; Blaise D; Reiffers J; Ferrant A; Bergmann L; Visani G; Cornelissen J; De Witte T; Bosi A; Frassoni F; Gorin NC
    Br J Haematol; 2000 Aug; 110(2):308-14. PubMed ID: 10971386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial.
    Reiffers J; Gaspard MH; Maraninchi D; Michallet M; Marit G; Stoppa AM; Corront B; David B; Gastaut JA; Scotto JJ
    Br J Haematol; 1989 May; 72(1):57-63. PubMed ID: 2660902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group.
    Attal M; Blaise D; Marit G; Payen C; Michallet M; Vernant JP; Sauvage C; Troussard X; Nedellec G; Pico J
    Blood; 1995 Aug; 86(4):1619-28. PubMed ID: 7632972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921).
    Oosterveld M; Suciu S; Verhoef G; Labar B; Belhabri A; Aul C; Selleslag D; Ferrant A; Wijermans P; Mandelli F; Amadori S; Jehn U; Muus P; Zittoun R; Hess U; Anak O; Beeldens F; Willemze R; de Witte T
    Leukemia; 2003 May; 17(5):859-68. PubMed ID: 12750698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
    Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Keating S; de Witte T; Suciu S; Willemze R; Hayat M; Labar B; Resegotti L; Ferrini PR; Caronia F; Dardenne M; Solbu G; Petti MC; Vegna ML; Mandelli F; Zittoun RA
    Br J Haematol; 1998 Sep; 102(5):1344-53. PubMed ID: 9753069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG).
    De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J
    Br J Haematol; 1990 Feb; 74(2):151-5. PubMed ID: 2180469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R; Gale RP
    Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis.
    Nathan PC; Sung L; Crump M; Beyene J
    J Natl Cancer Inst; 2004 Jan; 96(1):38-45. PubMed ID: 14709737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Gorin NC; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F
    Bone Marrow Transplant; 2000 May; 25(10):1053-8. PubMed ID: 10828865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in acute leukaemia.
    Gale RP; Champlin RE
    Clin Haematol; 1986 Aug; 15(3):851-72. PubMed ID: 3536244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
    Leukemia; 1994 Jun; 8(6):924-8. PubMed ID: 8207985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.